CN104351232A - Composition for preventing and curing orchid anthracnose - Google Patents
Composition for preventing and curing orchid anthracnose Download PDFInfo
- Publication number
- CN104351232A CN104351232A CN201410556137.5A CN201410556137A CN104351232A CN 104351232 A CN104351232 A CN 104351232A CN 201410556137 A CN201410556137 A CN 201410556137A CN 104351232 A CN104351232 A CN 104351232A
- Authority
- CN
- China
- Prior art keywords
- composition
- preventing
- curing
- anthracnose
- thiophanate methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a composition for preventing and curing orchid anthracnose. The composition comprises the active ingredients of thiophanate methyl and carbendazim, and the mass ratio of the thiophanate methyl to the carbendazim is (3-1):1. The composition has an excellent effect of preventing and curing the orchid anthracnose.
Description
Technical field
The present invention relates to a kind of composition preventing and treating cymbidium anthracnose.
Background technology
Cymbidium anthracnose is one of Major Diseases of orchid cultivation, and occurrence scope is quite extensive at home, all can occur throughout the year, especially spring, autumn to fall ill heavier.If disease can not get effective control, final blade is withered gradually from top to bottom, scattered syringe needle shape pore on later stage scab, i.e. the Spreading source that infects again of germ, and reduces ornamental value.
Summary of the invention
Object of the present invention provides a kind of composition preventing and treating cymbidium anthracnose.
In order to solve the problems of the technologies described above, the invention provides following technical scheme:
Prevent and treat a composition for cymbidium anthracnose, the active component of described composition is made up of thiophanate methyl and carbendazim, and the mass ratio of described thiophanate methyl and carbendazim is (3-1): 1.
Described composition contains pharmaceutic adjuvant.
Embodiment
Below in conjunction with preferred embodiment, the present invention will be described, should be appreciated that preferred embodiment described herein is only for instruction and explanation of the present invention, is not intended to limit the present invention.
Embodiment 1
By 70% commercially available thiophanate methyl wetting powder with 50% carbendazol wettable powder in mass ratio for 1:1 mixes, 900 times of water diluents of this medicament are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time every 7 days, totally 3 times, the total number of sheets of the control efficiency 95%(of 30 days 330 after medication).
Contrast 1: by 70% thiophanate methyl wetting powder dilute with water 800 times, spray dilution at cymbidium anthracnose their early stage, sprayed medicine 1 time every 7 days, totally 4 times, the total number of sheets of the control efficiency 79%(of 30 days 247 after medication).
Contrast 2: after 50% carbendazol wettable powder dilute with water 500 times, spray dilution at cymbidium anthracnose their early stage, sprayed medicine 1 time every 7 days, totally 3 times, the total number of sheets of the control efficiency 25%(of 30 days 150 after medication).
Embodiment 2
By 50% commercially available thiophanate methyl suspending agent with 40% carbendazim suspending agent in mass ratio for 2:1 mixes, its 900 times of water diluents are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time, totally 3 times, the total number of sheets of the control efficiency 96%(of 30 days 300 after medication) every 7 days.
Embodiment 3
By 50% commercially available thiophanate methyl suspending agent with 40% carbendazim suspending agent in mass ratio for 4:5 mixes, its 900 times of water diluents are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time, totally 3 times, the total number of sheets of the control efficiency 93%(of 30 days 280 after medication) every 7 days.
Last it is noted that the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (1)
1. prevent and treat a composition for cymbidium anthracnose, the active component of described composition is made up of thiophanate methyl and carbendazim, and the mass ratio of described thiophanate methyl and carbendazim is (3-1): 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410556137.5A CN104351232A (en) | 2014-10-20 | 2014-10-20 | Composition for preventing and curing orchid anthracnose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410556137.5A CN104351232A (en) | 2014-10-20 | 2014-10-20 | Composition for preventing and curing orchid anthracnose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104351232A true CN104351232A (en) | 2015-02-18 |
Family
ID=52518625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410556137.5A Pending CN104351232A (en) | 2014-10-20 | 2014-10-20 | Composition for preventing and curing orchid anthracnose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104351232A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4164582A (en) * | 1976-04-13 | 1979-08-14 | Kemira Oy | Synergistic fungicidal compositions |
| CN1353933A (en) * | 2001-09-28 | 2002-06-19 | 唐永琦 | Medicine for silkworm and its preparation method |
| CN101411280A (en) * | 2008-12-12 | 2009-04-22 | 唐山师范学院 | Method for cultivating Phalaenopsis amabilis Bl. in day-light greenhouse in north area |
| CN103787785A (en) * | 2014-03-06 | 2014-05-14 | 郭志红 | Crop bactericide additive |
-
2014
- 2014-10-20 CN CN201410556137.5A patent/CN104351232A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4164582A (en) * | 1976-04-13 | 1979-08-14 | Kemira Oy | Synergistic fungicidal compositions |
| CN1353933A (en) * | 2001-09-28 | 2002-06-19 | 唐永琦 | Medicine for silkworm and its preparation method |
| CN101411280A (en) * | 2008-12-12 | 2009-04-22 | 唐山师范学院 | Method for cultivating Phalaenopsis amabilis Bl. in day-light greenhouse in north area |
| CN103787785A (en) * | 2014-03-06 | 2014-05-14 | 郭志红 | Crop bactericide additive |
Non-Patent Citations (3)
| Title |
|---|
| 易绮斐 等: "兰花主要病害及其防治", 《植物保护》, vol. 30, no. 1, 8 February 2004 (2004-02-08) * |
| 桂炳中: "多菌灵、苯菌灵和甲基托布津的科学使用", 《科学种养》, 1 February 2008 (2008-02-01), pages 7 - 2 * |
| 赵书梅: "蝴蝶兰炭疽病的发生与防治", 《河北农业科技》, 2 October 2004 (2004-10-02), pages 19 - 1 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021003557A (en) | Synergistic pesticidal compositions and methods for delivery of active ingredients. | |
| PH12014502717B1 (en) | Synergistic compositions for the protection of agrarian crops and the use thereof | |
| PH12015502539A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
| MY201105A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | |
| HRP20211824T1 (en) | Modulators of complement activity | |
| WO2017022962A8 (en) | Composition for preventing or treating immune disease, comprising ripk inhibitor as active ingredient | |
| EA201992862A1 (en) | Nasal Drug Forms of Dihydroergotamine | |
| PH12018501066A1 (en) | Plant growth regulator composition having synergistic effect | |
| CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
| WO2016142708A3 (en) | Pharmaceutical composition | |
| MY177933A (en) | Herbicidal composition comprising quizalofop-p | |
| UY36432A (en) | COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A DERIVATIVE OF (UNCLE) CARBOXAMIDE AND FUNGICIDE COMPOUND (S) | |
| UY37306A (en) | COMBINATIONS OF ACTIVE COMPOUNDS | |
| MX2015007065A (en) | Methods and compositions for treating hiv-associated diarrhea. | |
| EP3352750A4 (en) | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | |
| MX2021009219A (en) | Triamterene or nolatrexed for use in the treatment of phenylketonuria. | |
| EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| PH12019502510A1 (en) | Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof | |
| SG10201908089VA (en) | Novel dosing regimens of celgosivir for the treatment of dengue | |
| MX2018000092A (en) | New bicyclic lipolantipeptide, preparation and use as antimicrobial agent. | |
| WO2016137806A3 (en) | Doses and methods of administering telavancin | |
| CN104304293A (en) | Method for preventing and treating anthracnose of orchid | |
| CN104351232A (en) | Composition for preventing and curing orchid anthracnose | |
| MX2017012471A (en) | A synergistic insecticidal composition. | |
| CN104351221B (en) | A kind of compositions preventing and treating Cymbidium ensifolium (L.) Sw. southern blight |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150218 |